fda glp-1 warning news november 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers Trends In FDA FY 2025

Meanwhile, Lilly has reported positive Phase 3 topline results for its oral GLP-1 candidate Orforglipron in obesity, underscoring that the next battleground is likely to be pill-based scale-up, access, and brand-led persistence rather than efficacy alone

Only buy with a valid prescription

Prioritize strength training

For many babies in our NICU, this is life-saving medicine, said Roxanne Graham, supervisor of maternal and infant support services at Kennestone

This is one of the reasons I personally appreciate both approaches

Research suggests that higher protein intake during weight loss supports fullness and helps preserve lean muscle mass